好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

An MRI-Defined Measure of Cerebral Lesion Severity to Assess the Therapeutic Effect of Glatiramer Acetate in Multiple Sclerosis
Multiple Sclerosis
(-)
172
Authors/Disclosures
Gloria Kim (Brigham & Womens Hospital)
PRESENTER
No disclosure on file
Shahamat Tauhid, MD (Brigham & Women's Hospital) Dr. Tauhid has nothing to disclose.
Sheena Dupuy (Brigham and Women'S Hospital) No disclosure on file
Subhash Tummala, MD No disclosure on file
Fariha Khalid, MD (Brigham And Women's Hospital) No disclosure on file
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Rohit Bakshi, MD, FAAN Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.